Krishna Yeshwant - Jun 5, 2025 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role: Director, 10%+ Owner
Signature: /s/ Andrew Ashe, as Attorney-in-Fact for Krishna Yeshwant
Stock symbol: VERV
Transactions as of: Jun 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/6/2025, 05:00 PM
Previous filing: Jun 28, 2024
Next filing: Jul 28, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Yeshwant Krishna	Director, 10%+ Owner	C/O VERVE THERAPEUTICS, INC., 201 BROOKLINE AVENUE, SUITE 601, BOSTON	/s/ Andrew Ashe, as Attorney-in-Fact for Krishna Yeshwant	2025-06-06	0001585001

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERV	Stock Option (right to buy)	Award	$0	+42.2K		$0.00	42.2K	Jun 5, 2025	Common Stock	42.2K	$5.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date (the "Vesting Commencement Date") of the options is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or immediately prior to the first annual meeting of stockholders occurring after the grant date, in each case subject to the Reporting Person's continued service as a director.

Content

This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date (the "Vesting Commencement Date") of the options is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or immediately prior to the first annual meeting of stockholders occurring after the grant date, in each case subject to the Reporting Person's continued service as a director.